Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

VivoSim Labs, Inc. - Common Stock (NQ:VIVS)

0.3745 -0.0444 (-10.60%)
Streaming Delayed Price Updated: 12:28 PM EDT, Jul 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 842,287
Open 0.3930
Bid (Size) 0.3710 (1,100)
Ask (Size) 0.3790 (500)
Prev. Close 0.4189
Today's Range 0.3612 - 0.4000
52wk Range 0.4100 - 5.300
Shares Outstanding 8,716,953
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
MissionIRNewsBreaks – VivoSim Labs, Inc. (NASDAQ: VIVS) Announces $4 Million Private Placement
Via Investor Brand Network
Topics Animal Testing

Performance

YTD
-80.1%
-80.1%
1 Month
-63.6%
-63.6%
3 Month
-75.0%
-75.0%
6 Month
-78.4%
-78.4%
1 Year
-83.1%
-83.1%

More News

Read More
News headline image
VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services
From VivoSim Labs, Inc.
Via GlobeNewswire
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
Thursday's session: top gainers and losers ↗
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
VivoSim Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Healthcare Focused Institutional Investor
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
VivoSim Presents Data Showing Superiority to Competition in NAM Liver Tox Prediction at European Toxicology Meeting
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
VivoSim Platform Predicts Gastrointestinal Toxicity (Diarrhea) in an AI Model Trained on Human Intestinal Model Results – Without Animal Testing
From VivoSim Labs, Inc.
Via GlobeNewswire
Which stocks are moving before the opening bell on Wednesday? ↗
Via Chartmill
News headline image
VivoSim Announces Pricing of up to a $4 Million Public Offering
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCs
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
VivoSim to Debut Antibody Drug Conjugate Data, representing a major new market for NAMkind models, at Society of Toxicology Meeting in San Diego
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
Why Is VIVS Stock Up 79% Today? ↗
Via Stocktwits
Topics Animal Testing
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
Check out the stocks that are attracting the most attention and driving market activity. ↗
Via Chartmill
Top movers analysis in the middle of the day on 2026-01-30: top gainers and losers in today's session. ↗
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
These stocks are moving in today's session ↗
Via Chartmill
News headline image
Roadzen Inc. (NASDAQ: RDZN) Accelerates U.S. Expansion with Strategic Acquisition – Surges on Record Volume – More Stocks Inside
Via AB Newswire
Topics Artificial Intelligence
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga

Frequently Asked Questions

Is VivoSim Labs, Inc. - Common Stock publicly traded?
Yes, VivoSim Labs, Inc. - Common Stock is publicly traded.
What exchange does VivoSim Labs, Inc. - Common Stock trade on?
VivoSim Labs, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for VivoSim Labs, Inc. - Common Stock?
The ticker symbol for VivoSim Labs, Inc. - Common Stock is VIVS on the Nasdaq Stock Market
What is the current price of VivoSim Labs, Inc. - Common Stock?
The current price of VivoSim Labs, Inc. - Common Stock is 0.3745
When was VivoSim Labs, Inc. - Common Stock last traded?
The last trade of VivoSim Labs, Inc. - Common Stock was at 07/27/26 12:28 PM ET
What is the market capitalization of VivoSim Labs, Inc. - Common Stock?
The market capitalization of VivoSim Labs, Inc. - Common Stock is 3.26M
How many shares of VivoSim Labs, Inc. - Common Stock are outstanding?
VivoSim Labs, Inc. - Common Stock has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.